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The Swiss Society for Biomaterials (SSB) has hosted the
22nd European Conference on Biomaterials—ESB 2009
from September 7 to September 11, 2009, in the Beaulieu
Convention Center Lausanne. The ESB conferences are the
annual conferences of the European Society for Biomate-
rials (ESB) taking place the three years between two World
Biomaterials Congresses.
1044 regular abstracts ?23 last minute abstracts were
submitted for presentation at ESB 2009 exceeding by far
the submissions to previous European Biomaterials Con-
ferences. After rigorous reviewing and invitation, the
conference program finally was composed of 10 plenary
lectures, 4 award lectures (Jean Leray and George Winter,
both for 2008 and 2009), 26 keynote lectures, of these half
invited and half selected following the recommendations of
the abstract reviewers, 156 regular talks, and 630 posters.
Figure 1 shows the thematic allocation of all submitted
abstracts, oral and posters, to the master keywords of the
conference. From this figure becomes obvious that the
trends and topics analyzed after the World Biomaterials
Congress 2008 principally continued for the ESB 2009 [1].
ESB 2009 had a very impressive scientific program with
world-renowned plenary speakers and presenters. Posters
were seen as an indispensable part of the ESB 2009.
Therefore, all posters were visible on all four days of the
ESB 2009. The poster sessions, all breaks and special
events provided excellent opportunities for in-depth dis-
cussions, to gain new international contacts for future
collaborations, and to exchange ideas.
1201 attendees from 44 countries coming from all
continents participated in the ESB 2009, a number slightly
higher than at ESB 2005 in Sorrento, Italy. Figure 2 pro-
vides some details of the attendance. The graph identifies
Switzerland, UK, Germany, Spain, Italy, and France as the
countries with the highest number of participants. How-
ever, also the attendance from the oversea countries Japan,
USA, Brazil, and Australia was good.
ESB 2009’s concept of dedicating one of the five par-
allel session lines throughout the day to a ‘‘Theme of the
Day’’ found wide acceptance. Each conference day started
with an ESB award lecture followed by a plenary lecture on
clinical problems within a ‘‘Theme of the Day’’ as well as a
plenary lecture of the state of the art in research of that
area. Particular highlights of the ESB 2009 were the ple-
nary lectures of the opening and closing ceremonies pre-
sented by Prof. Jeffrey A. Hubbell, Switzerland, and Prof.
Buddy D. Ratner, USA. Pre-meeting and during meeting
workshops, which were mainly educational completed the
scientific program.
In addition to the ‘‘Theme of the Day’’, ESB 2009 has
initiated accreditation by the European Accreditation
Council for Continuing Medical Education (EACCME) to
provide CME credits. The Schweizerische Gesellschaft fu¨r
Orthopa¨dische Chirurgie (SCO) allocated 25 points. The
European Orthopedic Research Society (EORS) was
brought as a new sister society to the ESB while the con-
nections to current ESB sister societies were re-strength-
ened by incorporation of special sessions into the program.
ESB 2009 further strengthened the scientific basis of
the traditional ESB core topics while encouraging the
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interaction with both the clinical and industrial side of
biomaterials. ESB 2009 has drawn on the extensive Med-
Tech industry within Switzerland to bring closer working
relationships with industry. More than 20 companies were
present with an exhibition booth and a special exhibitor
evening took place at the ‘‘Industrial Day’’.
ESB 2009 has also introduced conflict of interest state-
ments (Compulsory Presentation Statements) to let ESB
2009 participants better interpret posters and talks declaring
any potential conflict of interest that presenters might have
with the presented data. This will need more enforcement
for future meetings, as this was a partial success.
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Fig. 1 Thematic abstract submission (master keywords) before evaluation. Black abstracts submitted to be considered as oral contribution, grey
abstracts submitted for posters
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Fig. 2 Attendance at ESB 2009
844 J Mater Sci: Mater Med (2010) 21:843–845
123
ESB 2009 succeeded to connect biomaterial research
with current clinical problems to produce progressive
translational research and was the venue to present and
discuss basic, applied/translational and clinical research in
a multi-disciplinary environment. This special issue of
JMSMM is a collection of invited contributions proposed
by reviewers during the reviewing and selection process.
The organizers again thank all institutions, organiza-
tions, and companies that have supported ESB 2009 and
also recognize the efforts of all committee members and
reviewers who have helped to organize the scientific
program, workshops, forums, exhibition and special events.
However, finally, the activities of the participants made the
ESB 2009 a very successful and rewarding meeting.
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